Later, R. Gajbhiye et al. showed the high diagnostic accuracy of new biomarkers, particularly, the antibodies to various TPM and TMOD epitopes, for early stages of endometriosis (I–II), with the sensitivity of 52–68% and specificity ≥80%, which were higher than those of the CA-125 (24% and 89%, respectively) [22]. This evidence concerns the gene TMOD1 and endometriosis.